MJN, within the Research and Development Grant program, Horizon2020, Phase 2 of the European Commission, is developing a system of big data and artificial intelligence that will be able to find relationships between epileptic seizures and other personal data such as level of activity, general health, food intake, etc., which in the future will generate a significant volume of data.

To test and validate the operation, both about the big data and also about the first version of the Social-SERAS mobile app, MJN has initiated a pilot test where 20 volunteers, some of them selected with the help of ALCE, are already using the mobile application developed by Mjn.

The information gathered by the application will be managed and processed on a cloud support and from there it will be transferred to the big data module. The main functionality of this module will be to offer the MJN technical department a set of information based on historical data thanks to the amount of information that will be collected by the Social-SERAS app. The first functional version of the Social-SERAS app will allow to:

• Record the daily activity data of users using the sensor of the mobile phone itself.

• Manually record the timing of each epilepsy crisis and its intensity.

• Fill a “life notebook” test with various questions.

This information will be used to improve the general knowledge of epilepsy in relation to life habits

The data will be treated completely anonymously by all current data protection protocols.

This information, in the future, should serve to improve the general knowledge of epilepsy concerning life habits and hopefully it will be useful for the scientific community in the medium term.

MJN continues to work towards achieving its objectives to find solutions that help people with epilepsy and to improve the knowledge of the disease. And in this way, we are delighted to find entities that join these objectives voluntarily. For all of this, THANK YOU ALCE!

Leave a Reply

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.